# Positron Corporation to acquire FDA 510(k) for NeuSight PET-CT from Neusoft subsidiary

Positron Corporation has entered an agreement to acquire the FDA 510(k) clearance for the NeuSight PET-CT imaging system from Neusoft Medical Systems' subsidiary Shenyang Intelligent Neuclear Medical Technology Co. The deal value was not disclosed.

- Type: Acquisition
- Announced: 2024-06-12
- Where: United States
- Status: announced
- Products: NeuSight PET-CT imaging system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Neusoft Medical Systems](https://endata.com/companies/38408.md) (partner)
- [Positron Corporation](https://endata.com/companies/71717.md) (acquirer)
- [Shenyang Intelligent Neuclear Medical Technology Co.](https://endata.com/companies/77990.md) (target)

## Sources

- [centralcharts.com](https://www.centralcharts.com/en/146933-positron-corp/news/4715364-positron-corporation-enters-agreement-to-acquire-fda-510-k-for-neusight-pet-ct), 2024-06-12: "Gaining the 510(k) is a significant milestone in Positron’s mission to offer outstanding PET-CT technology and solutions to healthcare practices and hospitals serving both the cardiac and oncology segments of molecular imaging."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.